United States · Funded startup

Who invested in Alpine Immune Sciences

3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$199Mraised across 3 rounds since 2015, from 3 sources

$1.3MSeed$48MSeries A$150MRound
Latest round
Round, $150MNov 2023
Step-upi
3.1×
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20152017201920212023
$1.3MSeed$48MSeries A$150MRound
First round
Seed, $1.3M
Jan 2015
Biggest round
$150M
Round · Nov 2023
Usual gap between rounds
7.4 years
the median of 2

The rounds

  1. Nov 2023
    Round$150M4 new1 returning

    Source recorded

  2. Jun 2016
    Series A$48M1 new

    Reported by BusinesswireSEC filing: $10M sold, first sale Jun 2016

  3. Jan 2015
    Seed$1.3M

    No investor was named in the report.

    From a historical funding recordSEC filing: $1.0M sold, first sale Jan 2015

Founders and team

From the SEC filings it signed: 4 on the team.

  • James Paul RickeySenior Vice President and Chief Financial Officeri
  • Mitchell Paul GoldExecutive Chairman and Chief Executive Officeri
  • Stanford Paul PengPresident and Head of Research and Developmenti
  • Zelanna Paul GoldbergExecutive Officeri

On the board, as filediChristopher Paul PeetzCui Paul XiangminJames Paul TopperJay Paul VenkatesanNatasha Paul HerndayPeter Paul ThompsonRobert Paul Conway

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

OrbiMedPrivate equity2rounds
TCGPrivate equity1round
Omega FundsVC firm1round
Samsara BioCapitalVC firm1round
TCG CrossoverVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Alpine Immune Sciences as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Decheng CapitalVC firmPer its own site

Quick answers about Alpine Immune Sciences

Who invested in Alpine Immune Sciences?

Alpine Immune Sciences's investors include OrbiMed, TCG, Omega Funds, Samsara BioCapital and TCG Crossover.

How much has Alpine Immune Sciences raised?

Alpine Immune Sciences has raised $199M across 3 rounds since 2015.

When did Alpine Immune Sciences last raise?

Alpine Immune Sciences's most recent round was an Undisclosed round of $150M in Nov 2023.

What was Alpine Immune Sciences's biggest round?

Its most recent round, $150M in Nov 2023, is also its largest on record.

Who backed Alpine Immune Sciences first?

Alpine Immune Sciences's first round on record, in Jun 2016, was backed by OrbiMed.

What stage is Alpine Immune Sciences at?

Alpine Immune Sciences's latest named round is an Undisclosed round, in Nov 2023.

Where is Alpine Immune Sciences based?

Alpine Immune Sciences is based in the United States.

Companies like Alpine Immune Sciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.